Document Detail

Role of progestins in contraception.
MedLine Citation:
PMID:  15715527     Owner:  NLM     Status:  MEDLINE    
Progestins have been used for contraception for more than 30 years. The main goal was to develop a contraceptive method devoid of the metabolic or clinical side-effects associated with the use of estrogens. The development of new contraceptive methods and formulations is time-consuming and requires devotion, belief, and also strong economical basis. As a result of this endeavor new methods have been developed: oral progestins, implants, injectables, intrauterine hormonal systems, and vaginal rings. Progestin-only contraceptives may be preferable in some situations, which have absolute or relative contraindications to estrogen, side-effects to estrogen containing hormonal contraception, lactation, and comfort and feasibility of formulations for long-term use. At present, emergency contraception is also performed with progestin.
Risto Erkkola; Britt-Marie Landgren
Related Documents :
3293337 - Echographic evaluation of the incrustation of intrauterine contraceptive devices (iud).
1519497 - A new zealand randomized comparative study of three iuds (nova-t, mlcu375, mlagcu250): ...
2489987 - Contraceptive method switching over women's reproductive careers: evidence from malaysi...
19305327 - Interest in intrauterine contraception among seekers of emergency contraception and pre...
22052087 - Transport of nanoparticles through the placental barrier.
22407137 - Caffeinated beverage and soda consumption and time to pregnancy.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Acta obstetricia et gynecologica Scandinavica     Volume:  84     ISSN:  0001-6349     ISO Abbreviation:  Acta Obstet Gynecol Scand     Publication Date:  2005 Mar 
Date Detail:
Created Date:  2005-02-17     Completed Date:  2005-03-30     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0370343     Medline TA:  Acta Obstet Gynecol Scand     Country:  Denmark    
Other Details:
Languages:  eng     Pagination:  207-16     Citation Subset:  IM    
Department of Obstetrics and Gynecology, University Central Hospital, Turku, Finland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cervix Mucus / drug effects
Contraception / methods*
Contraceptive Agents, Female / adverse effects,  pharmacology*
Contraceptive Devices, Female*
Contraceptives, Oral
Contraceptives, Oral, Combined
Drug Implants
Endometrium / drug effects
Fallopian Tubes / drug effects
Intrauterine Devices
Ovulation / drug effects
Progesterone Congeners / adverse effects,  pharmacology*,  physiology
Reproductive Control Agents / administration & dosage,  adverse effects
Reg. No./Substance:
0/Contraceptive Agents, Female; 0/Contraceptives, Oral; 0/Contraceptives, Oral, Combined; 0/Drug Implants; 0/Progesterone Congeners; 0/Reproductive Control Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Application of RNA interference to study stem cell function: current status and future perspectives.
Next Document:  Normal labor associated with changes in uterine heparan sulfate proteoglycan expression and localiza...